Price Caps Not The Answer: Apollo Hospitals Eyes 100 Bps Cost Cut Amid Expansion
Apollo Hospitals set out an expansion in an infrastructure development.
· NDTV Profit
Reddy remarked that India requires good healthcare and infrastructure, along with stressing the need to create more jobs.
The analysis
Apollo Hospitals reported movement of 100 Bps. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -3.5% on the day at ₹7,643.00, and has returned -13.0% over three months. It sits 16% below its 52-week high. The pharma & healthcare sector has moved +0.1% over the same period, so Apollo Hospitals is running 13.1 points behind its peers.
For Apollo Hospitals, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.
Why it matters
- Infra spending is both an economic-cycle signal and a direct order pipeline for capital-goods names.
Market context
- The company directly in focus is APOLLOHOSP.
- Sector exposure: Pharma & Healthcare.
- The immediate tone of coverage reads positive.
In this story
Related coverage
Stock Market Crash LIVE: Sensex Tanks Over 1,200 Points, Nifty 50 Below 22,200; ITC, JSW Steel, IndiGo Among Top Losers
Eutelsat OneWeb awaits final approvals, says India infrastructure is ready
INR vs USD: Rupee near 97/dollar; how TCS, Sun Pharma, Tata Steel, SRF may gain from weaker currency? Experts explain
Pharma stocks to buy ahead of Q2 results: Acutaas Chemicals, Mankind Pharma, Ipca Labs - Max upside? Target price
From roads to solar: DBL plans ₹15,000 crore energy infrastructure push